Real-world rates of suspected endophthalmitis after injections similar to clinical trial rates

CHICAGO — In a large retrospective review of real-world rates of endophthalmitis after intravitreal anti-VEGF and steroid injections, rates were low and similar to reported rates in clinical trials, according to a speaker here.
“The rates were low, similar to reported rates of clinical trials. ... The majority of patients were able to regain vision within the first 2 months following the suspected endophthalmitis,” Dilsher S. Dhoot, MD, said at the American Society of Retina Specialists annual meeting.
The study of electronic medical records from Vestrum Health Retina Database

Full Story →